BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
34.17
-0.68 (-1.95%)
At close: May 9, 2025, 4:00 PM
34.09
-0.08 (-0.22%)
After-hours: May 9, 2025, 6:14 PM EDT

BridgeBio Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
540.6681.1375.94376.69393.77356.08
Upgrade
Short-Term Investments
--58.9595.23442.89251.01
Upgrade
Cash & Short-Term Investments
540.6681.1434.88471.92836.66607.09
Upgrade
Cash Growth
4.02%56.62%-7.85%-43.59%37.81%11.19%
Upgrade
Accounts Receivable
115.274.721.7517.0819.75-
Upgrade
Receivables
115.274.721.7517.0819.75-
Upgrade
Prepaid Expenses
32.1331.0424.3121.9232.2735.59
Upgrade
Restricted Cash
0.130.1316.6537.930.180.14
Upgrade
Other Current Assets
3.13.7----
Upgrade
Total Current Assets
695.17720.69477.59548.85888.86642.82
Upgrade
Property, Plant & Equipment
13.8612.7819.8425.2545.9736.83
Upgrade
Long-Term Investments
128.19143.751.6---
Upgrade
Other Intangible Assets
27.823.9326.3228.7144.93-
Upgrade
Other Long-Term Assets
16.6118.221.0320.2233.0323.93
Upgrade
Total Assets
881.64919.34546.38623.041,013703.59
Upgrade
Accounts Payable
27.539.6210.6611.5611.888.95
Upgrade
Accrued Expenses
103.25124.08116.9795.54116.7571.9
Upgrade
Current Portion of Long-Term Debt
-----1.46
Upgrade
Current Portion of Leases
5.214.514.133.684.943.8
Upgrade
Current Unearned Revenue
11.6214.66.18.16--
Upgrade
Other Current Liabilities
4.51.662.51.59.55
Upgrade
Total Current Liabilities
152.11154.4143.84121.43135.0795.65
Upgrade
Long-Term Debt
1,8481,7211,7271,7081,704475.86
Upgrade
Long-Term Leases
4.924.78.9812.2717.4314.68
Upgrade
Long-Term Unearned Revenue
17.5117.13.737.1--
Upgrade
Long-Term Deferred Tax Liabilities
-----1.1
Upgrade
Other Long-Term Liabilities
497.65479.385.6319.5422.078.42
Upgrade
Total Liabilities
2,5202,3771,8891,8681,878595.7
Upgrade
Common Stock
0.20.20.180.160.150.13
Upgrade
Additional Paid-In Capital
1,9381,9031,481938.7841.531,021
Upgrade
Retained Earnings
-3,264-3,096-2,561-1,918-1,437-888.76
Upgrade
Treasury Stock
-323.28-275-275-275-275-75
Upgrade
Comprehensive Income & Other
-0.010.03-0.33-0.130.19
Upgrade
Total Common Equity
-1,648-1,468-1,354-1,255-870.4157.91
Upgrade
Minority Interest
9.7310.2911.729.694.8449.98
Upgrade
Shareholders' Equity
-1,639-1,458-1,343-1,245-865.58107.89
Upgrade
Total Liabilities & Equity
881.64919.34546.38623.041,013703.59
Upgrade
Total Debt
1,8581,7311,7401,7241,726495.79
Upgrade
Net Cash (Debt)
-1,318-1,049-1,305-1,252-889.51111.31
Upgrade
Net Cash Growth
------77.07%
Upgrade
Net Cash Per Share
-6.97-5.64-8.02-8.49-6.160.94
Upgrade
Filing Date Shares Outstanding
189.88190.19175.83151.37147.61146.54
Upgrade
Total Common Shares Outstanding
189.83190.04175.08150.63147.34122.85
Upgrade
Working Capital
543.07566.29333.75427.43753.79547.18
Upgrade
Book Value Per Share
-8.68-7.72-7.73-8.33-5.910.47
Upgrade
Tangible Book Value
-1,676-1,492-1,381-1,283-915.3557.91
Upgrade
Tangible Book Value Per Share
-8.83-7.85-7.89-8.52-6.210.47
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q